Amundi Asset Management US’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | $30.5M | Sell |
|
|||||
|
2020
Q4 | $28.3M | Sell |
|
|||||
|
2020
Q3 | $36.4M | Buy |
|
|||||
|
2020
Q2 | $34M | Buy |
|
|||||
|
2020
Q1 | $19.2M | Sell |
|
|||||
|
2019
Q4 | $23.2M | Buy |
|
|||||
|
2019
Q3 | $14.3M | Buy |
|
|||||
|
2019
Q2 | $10.6M | Sell |
|
|||||
|
2019
Q1 | $14M | Buy |
|
|||||
|
2018
Q4 | $9.69K | Buy |
|
|||||
|
2018
Q3 | $11.2M | Sell |
|
|||||
|
2018
Q2 | $13.5M | Buy |
|
|||||
|
2018
Q1 | $12.3M | Sell |
|
|||||
|
2017
Q4 | $16.5M | Buy |
|
|||||
|
2017
Q3 | $11.2M | Sell |
|
|||||
|
2017
Q2 | $11.7M | Buy |
|
|||||
|
2017
Q1 | $4.47M | Buy |
|
|||||
|
2015
Q4 | – | Sell |
|
|||||
|
2015
Q3 | $50.8M | Buy |
|
|||||
|
2015
Q2 | $75.5M | Buy |
|
|||||
|
2015
Q1 | $50.6M | Buy |
|
|||||
|
2014
Q4 | $46.9M | Buy |
|
|||||
|
2014
Q3 | $25.3M | Buy |
|